IL174172A - Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same - Google Patents

Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same

Info

Publication number
IL174172A
IL174172A IL174172A IL17417206A IL174172A IL 174172 A IL174172 A IL 174172A IL 174172 A IL174172 A IL 174172A IL 17417206 A IL17417206 A IL 17417206A IL 174172 A IL174172 A IL 174172A
Authority
IL
Israel
Prior art keywords
cell
psgl
multimeric compound
binding
cells
Prior art date
Application number
IL174172A
Other languages
English (en)
Other versions
IL174172A0 (en
Original Assignee
Abgenomics Cooperatief Ua
Abgenomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Abgenomics Cooperatief Ua, Abgenomics Corp filed Critical Abgenomics Cooperatief Ua
Publication of IL174172A0 publication Critical patent/IL174172A0/en
Publication of IL174172A publication Critical patent/IL174172A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL174172A 2003-09-15 2006-03-08 Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same IL174172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1
PCT/US2004/029520 WO2005027831A2 (en) 2001-08-03 2004-09-09 Modulators of p-selectin glycoprotein ligand 1

Publications (2)

Publication Number Publication Date
IL174172A0 IL174172A0 (en) 2006-08-01
IL174172A true IL174172A (en) 2011-12-29

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174172A IL174172A (en) 2003-09-15 2006-03-08 Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same

Country Status (16)

Country Link
EP (1) EP1663290A4 (de)
JP (1) JP5808879B2 (de)
KR (1) KR101159140B1 (de)
CN (1) CN1852730B (de)
AU (1) AU2004273807B2 (de)
BR (1) BRPI0414402A (de)
CA (1) CA2538284C (de)
EC (1) ECSP066507A (de)
IL (1) IL174172A (de)
NO (1) NO20061306L (de)
NZ (1) NZ546203A (de)
RU (1) RU2407539C2 (de)
SG (1) SG146670A1 (de)
TW (2) TWI359024B (de)
UA (1) UA91004C2 (de)
ZA (1) ZA200602151B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120085921A (ko) * 2004-05-11 2012-08-01 압제노믹스 코오페라티에프 유.에이. Ｔ 세포 사멸 유도성 에피토프
WO2009139459A1 (ja) * 2008-05-15 2009-11-19 国立大学法人 岡山大学 Ｐｓｇｌ－１阻害によるメタボリックシンドロームの予防及び治療法
US10472422B2 (en) * 2016-01-08 2019-11-12 Abgenomics International Inc. Tetravalent anti-PSGL-1 antibodies and uses thereof
CN115887659A (zh) * 2022-11-23 2023-04-04 中山大学附属第七医院(深圳) 终末耗竭t细胞群“tcf19+pd1+tim3+cd8+”的鉴定及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68913658T3 (de) * 1988-11-11 2005-07-21 Stratagene, La Jolla Klonierung von Immunglobulin Sequenzen aus den variablen Domänen
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ZA973051B (en) * 1996-04-24 1998-10-12 Genentech Inc Type c lectins
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Also Published As

Publication number Publication date
EP1663290A4 (de) 2009-07-01
ECSP066507A (es) 2006-10-10
ZA200602151B (en) 2013-08-28
CN1852730B (zh) 2012-05-30
KR101159140B1 (ko) 2012-06-22
TWI359024B (en) 2012-03-01
NO20061306L (no) 2006-06-14
RU2407539C2 (ru) 2010-12-27
KR20060088104A (ko) 2006-08-03
UA91004C2 (uk) 2010-06-25
TW200513262A (en) 2005-04-16
CA2538284C (en) 2015-10-20
CA2538284A1 (en) 2005-03-31
AU2004273807A1 (en) 2005-03-31
BRPI0414402A (pt) 2006-11-14
CN1852730A (zh) 2006-10-25
JP5808879B2 (ja) 2015-11-10
RU2006112399A (ru) 2006-08-10
EP1663290A2 (de) 2006-06-07
SG146670A1 (en) 2008-10-30
JP2007533618A (ja) 2007-11-22
TW201012472A (en) 2010-04-01
NZ546203A (en) 2009-05-31
IL174172A0 (en) 2006-08-01
AU2004273807B2 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
US8628775B2 (en) Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds
US8298540B2 (en) Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
AU2002305041A1 (en) Modulators of P-selectin glycoprotein ligand 1
CA2538284C (en) Modulators of p-selectin glycoprotein ligand 1
MXPA06002968A (en) Modulators of p-selectin glycoprotein ligand 1
HK1065489B (en) Modulators of p-selectin glycoprotein ligand 1
HK1124624B (en) Antibody binding p-selectin glycoprotein ligand 1 (psgl-1) for use in treating allergic disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed